We also demonstrate that MEN1611 has a cytostatic effect in vivo in xenograft NSCLC tumors in immunodeficient mice and impairs cancer cell growth through inhibition of constitutively activated AKT and mTOR pathways. Here, AKT1 is linked to cancer.